The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...

Market Research Report Highlights Key Trends, Drivers, and InnovationsThe DNA sequencing market has emerged as a cornerstone ...

As many as one third of newly diagnosed multiple myeloma (MM) cases are classified as high risk, with widely varying rates of ...

Genetic newborn screening supports early identification of a child’s critical condition, guiding to a better start in life.

This year, the GATE Life Sciences 2026 exam will be organised by IIT Guwahati. The official GATE Life Sciences syllabus PDF ...

Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide, an investigational cereblon E3 ligase modulator (CELMoD™), combined with standard ...

As September ushers in Cancer Awareness Month, it also brings with it stories of resilience, breakthroughs, and hope. In Pune ...

Thermo Fisher Scientific Inc. acts as a mission-critical supplier and service partner for the global life science industry.

The seven chimeric antigen receptor T-cell therapies approved in the United States have revolutionized treatment of blood cancers.Eight years after the first CAR-T product entered the market, members ...

BC, AOCNP, explains how ctDNA can inform prognosis, monitor disease progression, and guide treatment decisions in oncology.

A new test to help select colorectal cancer therapy is the first in a menu of rapid cartridge-based tests the firm is planning to support cancer testing.